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Osteogenesis imperfecta is an inherited disorder characterized by increased bone fragility, fractures, and osteoporosis,
and most cases are caused by mutations affecting the type I collagen genes. Here, we describe a new mouse model for
Osteogenesis imperfecta termed Aga2 (abnormal gait 2) that was isolated from the Munich N-ethyl-N-nitrosourea
mutagenesis program and exhibited phenotypic variability, including reduced bone mass, multiple fractures, and early
lethality. The causal gene was mapped to Chromosome 11 by linkage analysis, and a C-terminal frameshift mutation
was identified in the Col1a1 (procollagen type I, alpha 1) gene as the cause of the disorder. Aga2 heterozygous animals
had markedly increased bone turnover and a disrupted native collagen network. Further studies showed that
abnormal proa1(I) chains accumulated intracellularly in Aga2/þ dermal fibroblasts and were poorly secreted
extracellularly. This was associated with the induction of an endoplasmic reticulum stress-specific unfolded protein
response involving upregulation of BiP, Hsp47, and Gadd153 with caspases-12 and 3 activation and apoptosis of
osteoblasts both in vitro and in vivo. These studies resulted in the identification of a new model for Osteogenesis
imperfecta, and identified a role for intracellular modulation of the endoplasmic reticulum stress-associated unfolded
protein response machinery toward osteoblast apoptosis during the pathogenesis of disease.
Citation: Lisse TS, Thiele F, Fuchs H, Hans W, Przemeck GKH, et al. (2008) ER stress-mediated apoptosis in a new mouse model of Osteogenesis imperfecta. PLoS Genet 4(2): e7.
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Introduction
Mutations in type I collagen genes (COL1A1/2) typically lead
to Osteogenesis imperfecta (OI), the most common heritable
cause of skeletal fractures and bone deformation in humans
[1]. OI is classified into eight human subtypes, and to date
greater than 500 human COL1A1 mutations have been
reported representing a clinical heterogeneity dictated by
the complex array of mutations. Recently, novel molecules
and loci apart from classic type I collagens have been
implicated in both murine [2] and human [3–5] alternative
recessive forms of OI, thus expanding the genetic hetero-
geneity.
Type I collagen is the most common ubiquitously expressed
fibrous protein in the extracellular matrix (ECM) of con-
nective tissues with both biomechanical and physiological
functions [6]. Type I collagen initially exists as a procollagen
precursor with NH2- and COOH-terminal propeptide do-
mains with distinct roles. Type I procollagen molecules
consist of three polypeptide coiled subunit chains (two
proa1(I) and one proa2(I) chain) that self-associate in the
endoplasmic reticulum (ER), and require a highly coordi-
nated post-translational regulation. The helical procollagens
are deposited into the extracellular space, proteolytically
cleaved, and then organized into highly ordered collagen
fibrils covalently cross-linked to increase tensile strength and
rigidity. Apart from its biomechanical properties, type I
collagen stores key factors for remodeling maintenance, and
acts as an adhesive substrate with cellular receptors and other
matricellular components along its major ligand binding
regions [7]. These properties regulate complex intracellular
signal transduction pathways for tissue remodeling and
repair, immune response, polarization, migration, prolifer-
ation, differentiation, and cell survival within various cellular
contexts [8].
Based on detailed radiographic, molecular genetic and
morphological analyses, structural collagen mutations are
likely associated with lethal (type II) and moderate (types III
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and IV) forms of OI [1]. Type II OI represents the most severe
form of the disease accounting for ;20 % of cases, and the
heterogeneous clinical and biochemical aspects have been
described [9]. Most OI-II probands acquire new dominant
mutations in COL1A1/2, and a low frequency recurrence risk
can be the result of gonadal mosaicism in one of the parents
[10]. OI-II-related mutations behave in a dominant negative
manner as the mutant proa(I) proteins affect wild-type chain
registration and formation due to the polymeric nature of
assembly, impairing overall ECM stoichiometry and integrity.
Typically in OI-II cells, abnormal trimers are poorly passaged
through the secretory pathway, and are more vulnerable to
degradation and overmodification, thus the cytoprotective
unfolded protein response (UPR) is concordantly instigated
[11–13].
Despite the observation of machinery involving BiP
chaperones that might target most defective procollagens
for subsequent proteasomal degradation in OI-II cells [13],
the direct activation of apoptosis has not been shown to date.
Here, we provide the first report on the isolation, cloning and
characterization of the skeletal phenotype in a novel ENU-
induced mouse line for human OI affecting the terminal C-
propeptide region of Col1a1. Furthermore, we provide
evidence of caspases-12 and 3-mediated apoptosis in Aga2
osteoblasts as a critical step toward increased cell death, thus
broadening our molecular insight into OI.
Results
Identification and Lethality of Aga2/þ
The original Aga2/þ mouse was identified in the Munich
ENU dominant mutagenesis screen [14], and displayed an
abnormal gait due to deformity of the hind limbs at five weeks
of age among the F1 mutagenized progeny. Aga2/þmales have
general reproductive success and the mutation segregated in
a dominant manner with complete penetrance (Table 1).
Aga2/þ females produced smaller litter sizes due to a
reduction in body size. A large subset of Aga2/þ animals
succumbed to postnatal lethality (Table 1), and featured
severe bone deformities and fractures. Aga2/þ inter se mating
yielded non-Mendelian ratios for dominant inheritance
suggesting embryonic lethality. Various embryonic stages
were investigated to determine gestational arrest in homo-
zygotes, which was estimated to occur around embryonic day
9.5 post coitum (data not shown).
Positional Cloning and Characterization of the Aga2
Mutation
Genetic mapping of the Aga2 locus was performed
following the standard outcross-backcross breeding strategy.
The mutation was mapped to a 700 kb domain on
Chromosome 11 (Figure S1). Within the Aga2 candidate
region, two skeletal genes were identified, Col1a1 (procollagen
type I, alpha1) and Chad (chondroadherin). Both candidate
genes were sequenced and a novel T to A transversion
mutation within intron 50 of Col1a1 was identified (Figure
1A). The Aga2 substitution generated a novel 39 splice
acceptor site and predicted a terminal frameshift beyond
the endogenous stop (Figure 1C). On the transcript level,
cDNA from homozygous embryos revealed a 16 bp expanded
transcript, whereas in heterozygous embryos equal levels of
two transcripts are present (Figure 1B). We further confirmed
the mutation at the genomic level. The T to A exchange
disrupted the endogenous MspA1I restriction site, generating
a cleavage-resistant allele in Aga2/þ samples (Figure 1B).
The C-terminal portion of human, and murine as well as
Aga2mutant Col1a1 was aligned highlighting specific residues
of importance (Figure 1C). Of interest, the most terminal
conserved cysteine C244 (aa 1451) was ablated, and 48
endogenous amino acids including the stop were frame-
shifted, concomitantly predicting 90 new amino acids beyond
the termination position. The Aga2 frameshift begins 56
Table 1. Mode of Inheritance and Postnatal Lethality
Mating Breeding Pairs Litter Size Postnatal Progeny
? 3 / ? /
þ/þ Aga2/þ þ/þ Aga2/þ
Aga2/þ 3 C3H 14 7.1 6 0.42 19 26 26 29
Lethal to weaning 2 (11%) 11 (42%) 3 (12 %) 17 (58%)
C3H 3 Aga2/þ 18 5.4 6 0.51 23 25 22 29
Lethal to weaning 3 (13%) 15 (60%) 1 (5 %) 20 (69%)
Aga2/þ 3 Aga2/þ 4 4.3 6 0.54 3 8 2 5
No homozygous
doi:10.1371/journal.pgen.0040007.t001
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Author Summary
Osteogenesis imperfecta (OI) is a heterogeneous collection of
connective tissue disorders typically caused by mutations in the
COL1A1/2 genes that encode the chains of type I collagen, the
principle structural protein of bone. Phenotypic expression in OI
depends on the nature of the mutation, causing a clinical
heterogeneity ranging from a mild risk of fractures to perinatal
lethality. Here, we describe a new OI mouse model with a dominant
mutation in the terminal C-propeptide domain of Col1a1 generated
using the N-ethyl-N-nitrosourea (ENU) mutagenesis strategy. Heter-
ozygous animals developed severe-to-lethal phenotypes that were
associated with endoplasmic reticulum stress, and caspases-12 and
3 activation within calvarial osteoblasts. We provide evidence for
endoplasmic reticulum stress–associated apoptosis as a key
component in the pathogenesis of disease.
amino acids away from the chain selectivity sequence [15].
Additionally, five new cysteines and a potential N-linked
oligosaccharide (CHO) attachment site were introduced. The
secondary structure of the Aga2 product was predicted to
remove the hydrophobicity of the short loop formed by the
last intra-chain disulphide bond (data not shown).
Aga2 Skeletal and Growth Phenotypes
Among all Aga2/þ animals, the gross skeletal phenotype was
discernable starting between days 6 - 11 after birth.
Heterozygous animals that survived to adulthood were
classified as moderately-to-severely affected and displayed
the hallmark dystrophic limb(s), long bone and pelvis
fractures, reduced body size, and generalized decreases in
DXA-based bone parameters (Figure 2 and Table S1; data
were collected from the German Mouse Clinic dysmorphol-
ogy primary screen [16]). Lethal animals developed thin
calvaria, hemorrhaging at joint cavities and intracranial sites,
scoliosis, provisional rib and long bone calluses and deform-
ities, body size deficit, pectus excavatum, gasping, cyanosis,
platyspondyly, edema of the eyes, greasy skin, and eczema
(Figure 2 and data not shown). Comminuted fractures
incurred signifying the severe brittleness of Aga2/þ bones
accompanied by many repair blastemas characteristic of a
type II OI phenotype.
The effect of the mutation on volumetric bone mineral
density (vBMD) and content (vBMC) was evaluated in adult
mice using in vivo peripheral quantitative computed tomog-
raphy (pQCT; Table S2). In Aga2/þ distal femora, trabecular
and cortical vBMD as well as cortical vBMC were substantially
decreased compared to controls. In contrast, the trabecular
vBMC was unchanged due to enlarged medullar areas
(suggesting elevated resorption in Aga2/þ). Collectively, these
results suggest potential defects in mineralization and/or
bone formation in Aga2/þmice.
Figure 1. The C-Propeptide Col1a1Aga2 Mutation
(A) Mutation scheme. In Aga2, splicing occurs at the new splice acceptor site (ag, highlighted red). The taat domain (underlined) harbors a putative
spliceosome branch site (*).
(B) Genotyping and presence of the extended transcript.
(C) Alignment of human and murine Col1a1 terminal C-propeptides and prediction of the Aga2 frameshifted sequence. The start of mouse exon 51 (52
in human) is marked by a blue line. The frameshifted cysteine (C244) is boxed in red, newly introduced cysteines are underlined in blue; the potential N-
linked oligosaccharide (CHO) attachment site is boxed in blue. Start of the human frameshift mutation described by Willing et al. [30] is boxed in black.
doi:10.1371/journal.pgen.0040007.g001
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Clinical Chemical and Hormone Analysis
Several serum biochemical and hormonal markers were
evaluated to detect possible bone metabolic disturbances
(Table S3). Total alkaline phosphatase (ALP) and osteocalcin
levels were significantly increased in both sexes in Aga2/þ
compared to littermate controls. In addition, circulating
TRACP 5b (an osteoclast marker) was significantly elevated in
Aga2/þ. No changes in inorganic phosphate levels were
observed (data not shown). Aga2/þ animals depicted a
significant increase in PTH levels. Furthermore, Aga2/þmice
yielded a distinct increase in calcitonin, which was more
pronounced in females. Taken together, the significantly
increased bone formation and resorption markers indicate
that in Aga2/þmice metabolic bone turnover is elevated. This
was further supported by histomorphometric analysis of bone
formation and resorption showing increased numbers of
endogenous osteoblasts and osteoclasts, an increased bone
formation rate (BFR) and a reduced mineral apposition rate
(MAR) in Aga2/þ bone samples (Figures S2, S3 and Table S4).
Altered Cellular and Collagen Structures in Aga2/þ
Fibroblast and type I collagen features in Aga2/þ connective
tissues were evaluated by transmission and scanning electron
microscopy (TEM and SEM). Aga2/þ dermis contained more
heterogeneous populations of fibroblasts with smaller nuclei,
aberrant dilated electron-dense ERs, lysosomes and empty
autophagic-like vacuoles interspersed throughout the cells
(Figure 3A and 3B). Aga2/þ ERs appeared contiguous with
secretory vesicles signifying the formation of ER associated
compartments. SEM studies on cortical nanostructure of
Aga2/þ samples depicted a less-parallel, less-densely packed
network of collagen bundles when compared to controls
(Figure 3C–3F).
Procollagen trafficking was assessed in immunofluores-
cence studies using dermal fibroblasts (Figure 4). To uncover
mature type I collagen integrity we used an antibody that was
directed against the triple helical domain and was also
capable of detecting procollagens (Figure 4A). Wild-type cells
depicted both intracellular and intact extracellular surface
staining (Figure 4B). In Aga2/þ cells, the intact type I collagen
surface stain was largely reduced while intracellularly retain-
ing procollagen molecules were stained (Figure 4C). Double
immunofluorescence staining of proa1(I) chains was per-
formed using antiserum LF-67 (Figure 4A), protein disul-
phide isomerase (PDI), and Golgi phosphoprotein 4
(GOLPH4) for detection of the ER and cis-Golgi apparatus,
respectively. Merged stainings showed proa1(I) chain reten-
tion within the ER (Figure 4E) but not in the cis-Golgi (Figure
4G), when compared to controls (Figure 4D and 4F). It is
speculated that aberrant procollagen molecules aggregate
into vesicular structures (Figure 4E, merged green dots),
which may be part of the proteasome. To further clarify the
intracellular abnormalities double immunofluorescence
staining of proa1(I) chains was performed using antiserum
LF-41 and b-actin antibody for the cytoskeleton. The LF-41
epitope resides within the wild-type terminal C-propeptide
Figure 2. Aga2/þ Skeletal and Growth Abnormalities
(A) Lateral lCT views of 12-wk-old male skeletons highlight the axial vertebrae, pelvis (white trace), and hind limb (encircled) defects in Aga2/þmice.
(B) Cranial features of a 16-d-old lethal Aga2/þmouse.
(C) Skeletal radiograph of a 16-d-old lethal Aga2/þ animal. Provisional-bony rib and long bone calluses and deteriorated pelvis depicted with arrows.
(D) Severe growth defects in Aga2/þ animals.
(E) Skeletal preparations.
doi:10.1371/journal.pgen.0040007.g002
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overlapping segment of the Aga2 frameshifted region and
captures only molecules that contain chains with the normal
C-propeptide (Figure 4A). Using antiserum LF-41, control
fibroblasts depict dynamic intracellular procollagen and
isoform trafficking to the infoldings of the plasma membrane
(Figure 4H). Contrarily, Aga2/þ fibroblasts retained intra-
cellular (wild-type) procollagen molecules at near peri-
nuclear regions (Figure 4I, arrow). Surface staining in both
wild type and Aga2/þ cells was limited given that the LF-41
antiserum was unable to discriminate mature, proteolysed
type I collagen in the ECM. Based on our results, the mutation
affected proa1(I) chain processing by blocking its ER-to-Golgi
anterograde transport, thus inhibiting vesicular exocytosis to
the matrix.
Altered Ex Vivo Osteogenic Activity in Aga2/þ Calvarial
Culture System
OB metabolism and function were characterized utilizing
the primary calvarial culture system. We determined the
growth curve of Aga2/þ primary OBs and observed a limited
saturation density within the stimulated samples (Figure 5A)
that was accompanied by a relative increase in ALP levels
until day 26 (Figure S4A). Also, Aga2/þ total protein and
mitochondrial reductase activity levels were significantly
increased (Figure S4B). Consistent with our immunofluor-
escence studies there was a clear reduction in the total
amount of secreted acid-soluble collagens tested in Aga2/þ
media (Figure S4B). Of note, unstimulated Aga2/þ OBs
depicted no significant change in cellular protein and
metabolic activity levels (data not shown).
To address the functional defects in Aga2/þ OBs, nodular
formation, growth and binding capacities were studied over
time (Figure S4C). The formation of bone-like nodules was
persistently reduced between days 9 and 16 in Aga2/þ. In
addition, the average area of individual Aga2/þ nodules was
reduced compared to controls. Lastly, a 3.2 fold comparative
increase in nodular dye-binding capacity was observed in
Aga2/þ (Figure S4C). Taken together, these results demon-
Figure 3. Electron Microscopical Findings in Dermal Fibroblasts and Cortical Bone
(A,B) TEM micrographs of wild-type and Aga2/þ fibroblasts. The rough endoplasmatic reticulum (rER) is engorged in Aga2/þ cells (bars, 2 lm for main, 1
lm for inset). Increased intracellular empty vacuoles (arrow heads) and lysomes (L) were present in Aga2/þ.
(C–F) SEMs of femoral endosteal surfaces reveal differences in organization of the collagen matrix (C,D) Outer cortical surface.
(E,F) Inner cortical surface.
doi:10.1371/journal.pgen.0040007.g003
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strate clear functional and metabolic disturbances in Aga2/þ
OBs.
Initiation of ER Stress-Induced Apoptosis in Aga2/þ OBs
To show involvement of key regulators of ER stress
response pathways, we performed qPCR studies using
primary calvarial OBs (Figure 5B). At days 16 and 26 in
culture (11 and 21 days after induction, respectively),
expression of the molecular chaperones genes Hspa5 (also
known as BiP/GRP78) and Serpinh1 (also known as Hsp47) was
upregulated ;1.5 – 2.2 folds above control. The expression of
Ddit3 (also known as Gadd153/chop), a transcription factor
involved in the induction of apoptosis, was ;3.7 folds higher
in Aga2/þ cells at day 26 compared to control levels. To
confirm the induction of cytoprotective unfolded protein
response (UPR) in Aga2/þ cells, Western analysis of BiP
protein expression was performed using primary calvarial
OBs. As shown in Figure 5C BiP protein levels were increased
compared to controls.
Within the context of ER-induced stress we investigated
cell apoptosis. The Aga2 mutation led to a combined relative
increase in the number of early-late stage TUNEL-positive
picnotic OBs compared to control (Figure 6E). At 16 days in
culture, Aga2/þpreparations depicted a 10 % relative increase
in the number of OBs, which contained aberrant caspase-12-
immunoreactivity (Figure 6A and 6B; 3.3 6 0.9 % þ/þ and
12.9 6 1.9 % Aga2/þ; p¼ 0.0007 Student t-test). For specificity,
proteolytic processing of procaspase-12 was evident only in
Aga2/þ samples via Western analysis (Figure 6G). Caspase-3/7
activation was independently confirmed depicting a signifi-
cant 9 % comparative increase in activity in Aga2/þ OBs
(Figure 6F). Lastly, activated caspase-3 immunoreactivity was
observed within femoral periosteum (Figure 6C and 6D).
Aga2/þ tissue contained elevated relative numbers of activated
caspase-3-positive OBs (28.9 6 2.7 % þ/þ and 42.6 6 4.1 %
Figure 4. Immunofluorescence Microscopy of Type I and proa1(I) Collagen in Aga2/þ Primary Dermal Fibroblasts
(A) Scheme depicting probe-specificity toward various isoforms (pN/CP, procollagen N/C-proteinase; telo, telopeptide domain).
(B,C) Mature type I collagen.
(D-G) Proa1(I) double immunofluorescence using antiserum LF-67, protein disulphide isomerase (PDI), and golgi phosphoprotein 4 (GOLPH4) for
detection of the ER and cis-Golgi apparatus, respectively. The combined panels (E) and (G) show proa1(I) chain retention within the ER, not in the cis-
Golgi respectively, when compared to controls (D,F). It is speculated that aberrant procollagen molecules aggregate into vesicular structures (E)
(merged green dots), which may be part of the proteasome.
(H,I) Proa1(I) double immunofluorescence using antiserum LF-41 and b-actin antibody for the cytoskeleton (arrow, aberrant procollagen). All nuclei
were counterstained with DAPI. Bars, 25 lm.
doi:10.1371/journal.pgen.0040007.g004
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Aga2/þ; p¼0.02 Student t-test), suggesting a 14 % comparative
basal increase in apoptosis. Also, TUNEL experiments
revealed increased numbers of DNA-fragmented OBs within
Aga2/þ periosteum (data not shown).
Discussion
ENU mutagenesis is a powerful approach to identify mouse
models for human skeletal disorders by generating novel
phenotypes. Human mutations affecting the a1/2(I) C-
propeptide coding and non-coding regions have been
identified less often than other types of mutations and reflect
strong variability in clinical outcomes. Here, we provide the
first report on the cloning and phenotypic description of the
novel mouse line Aga2, which bear a chemically induced
genetically stable mutation affecting the terminal C-propep-
tide domain of Col1a1. We provide evidence that abnormal
proa1(I) chains accumulated intracellularly and were poorly
secreted extracellularly. Furthermore, we show for the first
time that this was associated with the induction of an ER
stress-specific unfolded protein response (UPR) with caspases
12 and 3 activation and apoptosis of osteoblasts both in vitro
and in vivo. The Aga2 line provides a unique tool for
understanding the underlying mechanisms of the incurable
debilitating human disease Osteogenesis imperfecta (OI) and the
efficacy of novel therapeutic strategies.
Aga2/þ Skeletal Phenotypes
Aga2/þ mice feature phenotypic variability ranging from
postnatal lethality to moderate-to-severe changes including
increased bone fractures, fragility, deformity, osteoporosis,
and disorganized trabecular and collagen structures. Com-
pared to the lethal transgenic lines [17,18], the Aga2/þ
phenotype is stronger and associated with increased lethality,
but comparable to the BrtlIV knock-in (Col1a1G349C) line [19].
The biochemical serum and histomorphometric results of
Aga2/þ mice indicated an elevated bone turnover that is
described similarly for OI patients [20–23]. Our ex vivo
studies showed that Aga2/þ OBs deposited less collagen
matrix, and were overly active, affecting nodule growth and
function.
Aga2/þ proa1(I) Chain Defects and Human Case
Correlations
The procollagen triple helix proceeds from the carboxyl to
amino end, and this association is modulated by correct
folding via intra-chain disulphide bonds in the C-propeptide
region before chain association and inter-chain disulphide
linkage [24,25]. In certain C-propeptide OI-II lethal con-
ditions, the mutated proa1/2(I) chains can associate with
normal chains to form secreted triple helical procollagen
molecules despite alterations in endogenous disulfide bonds
[12,26], while in other lethal cases chain formation with the
mutated propeptide is entirely or largely precluded [27,28].
Based on these results, the lethal OI phenotypes are
heterogeneously derived from structural and/or cellular
metabolic defects.
At the biochemical level, we report significant increased
retention of aberrant procollagen molecules within Aga2/þ
cells, compromising cellular metabolism and the ECM.
Moreover, we show that the majority of accumulated chains
were wild type in nature. Gel analysis of cDNA showed
significant splicing of the new Aga2 splice site. Although
cryptic mRNA transcripts were readily available for trans-
lation, unstable mRNA decay and/or anomalies in transport
from the nucleus to the cytoplasm due to secondary structure
may have mediated low-level translation of mutant chains.
The presumptive elongated chain with newly introduced
cysteins and disruption of a crucial beta sheet due to the Aga2
mutation likely destabilized protein conformation, thus
affecting preferential chain assembly and proteolysis. Also,
a N-linked oligosaccharide unit was introduced capable of
altering intracellular processing and secretion of procolla-
gens as well [29].
Our findings were consistent with observations made by
Willing et al. [30] who investigated a human OI family that
harbored a mutation in the 3’ end of COL1A1, which ablated
the intra-chain disulfide cysteine as in the Aga2 condition.
Fitzgerald et al. [13] reported that the fate of mutated
unassembled C-propeptide chains from the proband de-
scribed by Willing et al. were intracellularly degraded in the
proteasome. Similar to Aga2, it was unclear if the mutated
chains ever incorporated into procollagen molecules causing
protein suicide and the expected downstream effects [31], or
involved an alternative mechanism to influence the clinical
outcome.
ER Stress and Degradation within Aga2/þ Cells
Many disorders result from the cell’s inability to export
mutated proteins and enzymes from the ER, including OI
[32,33]. Depending on the nature of the mutation, incorrectly
folded proa1/2(I) molecules are managed via multipartite
Figure 5. Anomalies in Aga2/þ Osteoblast Growth and Induction of
Cytoprotective Unfolded Protein Response
(A) Growth curve analysis of þ/þ and Aga2/þ primary calvarial culture
system.
(B) UPR, qPCR analysis of stimulated calvarial OBs. Values represent
means 6 SEM, where n ¼ 4–5 experiments (*p , 0.01 Student t-test).
(C) Western analysis of BiP using primary OBs.
doi:10.1371/journal.pgen.0040007.g005
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highly regulated sorting pathways in order to retain ER
homeostasis and to prevent the secretion of abnormal
proteins. The cytoprotective unfolded protein response
(UPR) involves the activation of complex regulatory ER stress
signaling mechanisms that can either repress protein syn-
thesis or upregulate ER-resident chaperons and other trans-
lation regulators [34]. BiP/Grp78, a central regulator of ER
function, was shown to bind to proa (I) chains from cell
strains, which harbored unique C-propeptide mutations that
inhibited chain association [11] and mediated intracellular
ER-degradation [12]. Contrarily, mutations that inhibit
folding in the triple helical domain of type I procollagen
chains do not result in abnormal BiP binding or induction
even though the aberrant molecules are retained within the
ER [35].
In Aga2/þ, the presence of dilated ERs and accumulation of
aberrant procollagens in the ER strongly support intra-
cellular trafficking defects and degradation within the
proximal region of the secretory pathway. We speculate that
aberrant procollagen molecules aggregated into vesicular
structures (Figure 4E), which are part of the proteasome.
Degradation did occur within more distal secretory compart-
ments by the presence of lysosome-like structures [36]. In
Aga2/þ OB cultures treated with ascorbate, BiP levels were
slightly upregulated implicating its constitutive involvement
during ER stress. Previous studies from Chessler et al.
suggested that in skin fibroblasts from OI patients with
mutations in the C-terminal propeptide BiP peaked about 48
hours after exposure to ascorbate and that longer exposure
resulted in decreasing levels [11]. As cells studied here were
Figure 6. Initiation of Apoptosis in Aga2/þ
(A,B) Caspase-12 immunofluorescence of 16-d-old stimulated OBs.
(C,D) Activated caspase-3 labeling of 12-wk-old distal femur depicting dying cells within the periosteum (white arrows) and cortical bone (red arrows).
Nuclei were stained with DAPI.
(E) Quantification of TUNEL stained 16-d-old stimulated calvarial OBs.
(F) Caspase-3/7 OB activity was measured via a fluorometric substrate assay.
(G) Western analysis of procaspase-12 using primary OBs. Results are presented as mean 6 SEM (*p¼ 0.0002 ANOVA, and **p¼ 0.04 Student t-test),
where n¼ 4 independent experiments. Bars, 50 lm in (A) and (B), 100 lm in (C) and (D) main panels, 20 lm in (C) and (D) insets. Arbitrary fluorescent
unit (AFU), bone marrow (Bm), cortical bone (Cx), low-present isoform (IS), periosteum (Ps).
doi:10.1371/journal.pgen.0040007.g006
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exposed to ascorbate continuously during growth as part of
their medium enrichment, we performed Western analysis
and confirmed increased BiP protein levels. Hsp47, another
molecular chaperone, which is part of the ‘quality control’
system for procollagens, is enhanced in certain OI cases [37].
In our studies, the degree of Hsp47 induction was also
elevated. Thus, in Aga2/þ both BiP and Hsp47 seemed to
choreograph the intracellular regulation of mutant type I
procollagens with concomitant induction of apoptosis.
Ex Vivo and In Vivo Evidence for Increased ER Stress-
Induced Apoptosis
Many diseases are associated with either inhibition or
increase of apoptosis [34,38], but to date the active involve-
ment of apoptosis during OI pathogenesis is inconclusive.
Caspase-12 is a specific mediator of the ER stress-induced
UPR within skeletal tissue [39]. In primary Aga2/þ OBs,
removal of the procaspase-12 adaptor protein-binding
domain was evident, and the processing of procaspase-12
demonstrated the ER stress origin of mutated proa1(I)
initiator signals. In addition, the presence of increased
activated caspase-3 and TUNEL-positive OBs in Aga2/þ
primary culture and periosteum also implicated a tendency
toward apoptosis commitment and cell death, respectively.
Although several models have been proposed for the direct
activation of caspase-12 the entire process has yet to be
described. The Bcl2 family-proteins are well-established
components of the apoptotic machinery, some of which are
associated with ER stress pathways. For example, Bim (Bcl2-
interacting mediator of cell death) activates caspase-12 via
translocating from the dynein-rich ER compartment upon
stress [40]. BiP is known to inhibit caspase-mediated cell
death by forming complexes with procaspases 7 and 12, and
BiP disassociation facilitates procaspase activation [41].
Gadd153/CHOP is a key transcription factor in the regulation
of cell growth, differentiation and ER stress-induced apop-
tosis. Gadd153 induces death by promoting ER client protein
load and oxidation via transcription of target genes, which
mediate apoptosis, presumably leading to caspase cascades
[34]. In our studies, Gadd153 was highly induced over time,
and was presumably triggered by mutated procollagens and
the modulation of ER stress signaling. Of interest, the anti-
apoptotic component Bcl2 is down regulated during ER stress
conditions attributed to Gadd153 upregulation, leading to
enhanced oxidation and apoptosis [42]. Thus, given the
upregulation of Gadd153 within Aga2/þ OBs, Bcl2 was likely
down regulated, exacerbating and contributing to cell death.
Further studies are necessary to elucidate the pro- and anti-
apoptotic components that modulated the severe clinical
outcome in Aga2/þ animals. In addition to severe long bone
deformities we observed immunological, blood, heart, lung
and energy metabolic defects pointing to a systemic effect of
the Col1a1mutation. Further experiments will be necessary to
elucidate the influence of the systemic defect on bone and
early lethality (unpublished data).
The molecular diversity of apoptosis in OI is unknown, and
it is unclear if the apoptotic program is a phenomenon of
type I procollagen mutations that severely affect chain
assembly and retention caused by triple helical versus C-
propeptide structural defects, or by both. Recently, Forlino et
al. [43] evaluated phenotype heterogeneity within the BrtlIV
knock-in OI mouse line and identified increased Gadd153
transcript and protein levels within calvaria of lethal animals.
In this study we isolated and characterized a unique mouse
model for OI, and provided evidence that the Aga2 C-
propeptide a1(I) mutation induced ER-mediated osteoblast
apoptosis that affected cellular function and metabolism,
which we now suggest to be a key component, among others,
that influenced disease severity in Osteogenesis imperfecta.
Materials and Methods
Antibodies and kits. Activated caspase-3 (R&D Systems, Germany),
caspase-12 (BD Pharmingen, Germany), anti-a-tubulin (Sigma, Ger-
many), b-actin, type I collagen, and BiP/GRP78 (all Abcam, UK), and
fluorescently labeled secondary antibodies (Molecular Probes, Ger-
many) were commercially purchased. Antisera LF-41 and -67 [44]
were generous gifts provided by Dr. L. Fisher (NIH, USA). The serum
biochemical analysis has been previously described [45]. The mouse
TRACP 5b (IDS Ltd), osteocalcin ELISA (BTI), and mouse/rat intact
PTH as well as calcitonin immunoradiometric assay (Immundiagnos-
tik, Germany) kits were commercially purchased. All measurements
were performed based on the manufacturers’ recommendations.
Animal housing and handling. Mouse husbandry was conducted
under a continuously controlled specific-pathogen-free (SPF) hygiene
standard according to the Federation of European Laboratory
Animal Science Associations (FELASA) protocols. Standard rodent
diet and water were provided ad libitum. All animal experiments were
conducted under the approval of the responsible animal welfare
authority.
Linkage analysis and Aga2 genotyping. The F1 dominant ENU
mutagenesis screen was conducted on the inbred strain C3HeB/FeJ
and has been previously described [14]. Aga2 was backcrossed to wild-
type C3H mice for five generations, and then outcrossed to C57BL/6J
(F1) and backcrossed to the outcrossed strain (N2). Phenotype-positive
N2 progeny were tail-genotyped with microsatellite markers. Recom-
bination fractions and map distances were calculated using Mapman-
ager QTX. All primers for sequencing are available upon request. For
genotyping, a PCR fragment containing the entire intron 50 of Col1a1
was generated using primers for-59-ggcaacagtcgcttcaccta-39 and rev-
59-ggaggtcttggtggttttgt-39. The product was then cleaved using
MspA1I for gel analysis.
Skeletal and radiological analysis. Skeletal preparations were
generated as previously described [46]. Simple and compound
fractures were grossly examined. Compression fractures were
evaluated using a dissecting microscope. For lCT scans (Tomoscope
10010m; VAMP, Germany), image reconstruction and visualization
were performed using the ImpactCB and ImpactView software
(VAMP), respectively. pQCT analysis was performed as previously
described [47].
Electron microscopy, histology, and histomorphometry. SEM was
performed as previously described [48]. For TEM, lower dorsal skin
was prepared as previously described [49]. Sample preparation,
embedding and double labeling experiments were performed as
previously described [50]. For the demonstration of endogenous ALP
and TRAP, the procedure of Miao and Scutt [51] was performed with
modifications. All bone histomorphometric parameters were derived
from the standardized nomenclature [52]. Non-sequential sections
were collected every 70 - 100 lm. All images and measurements were
captured and determined using an Axioplan2 workstation (AxioVi-
sion v3.1; Zeiss, Germany) and the ImageJ program (v1.36; NIH, USA).
Automatic color thresholding was applied to stacked image sets.
Labels were traced with minimal operator bias. 6 - 20 repeated
measurements were made per section using four non-sequential
sections, where n (4 - 6) equals the number of animals examined.
Western analysis. Dermal fibroblasts were cultured as previously
described [53]. For caspase-12 and BiP detection, cells were lysed in
RIPA buffer with protease inhibitors. Supernatants were analyzed
using the NuPAGE Novex gel system (Invitrogen, UK).
Primary OB culture and cellular assays.OBs were prepared from 3-
day-old pups with similar appearance as previously described [54].
Cells were plated at 2 3 104 cells/cm2 for all experiments. OB
differentiation was initiated via media exchange (i.e. a-MEM w/10 %
FCS, 2 mM glutamine, 1 % pen-strep, 50 lg/ml ascorbic acid, 10 mM
b-glycerophosphate). A minimum of four calvaria/genotype was
pooled representing an independent experiment (n) with four
repeated measurements. DNA, total protein, ALP and MTT (kit)
measurements were performed in 24-well plates as previously
described [55]. Caspase-3/7 activity was monitored using a fluorogenic
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substrate (Ac-DEVD-AMC; AXXORA, Germany) at excitation 380 nm
and emission 460 nm. Mineral content was quantified by establishing
an alizarin red standard curve and measuring dye release using 10 %
hexadecylpyridinium in 6-well plates at 570 nm. For nodule
characterization, samples were analyzed using the ImageJ software.
Indirect immunofluorescence and TUNEL analysis. Cells were
cultured on glass coverslips coated with poly-L-lysine. For immuno-
histochemical analysis, sodium citrate (10 mM, pH 6.0 in microwave)
and proteinase K (10 lg/ml, 37 8C) antigen retrieval methods were
performed, and the Vectastain ABC kit (Vector Labs, USA) utilized.
The TUNEL assay was performed with an ALP-conjugated kit (Roche,
Germany). Independent preparations (n ¼ 4) were analyzed with
repeated measurements. For cell culture, 300 - 400 cells were counted
per image field. For in vivo caspase-3 analysis, a region 0.4 mm from
the growth plate was analyzed, and 400 - 480 total cells were evaluated
within set regions (i.e. magnification field).
qPCR. RNA and cDNA were prepared as previously described [56].
qPCR was performed using the TaqMan and QuantiTect ready-to use
primers (Qiagen, Germany). Duplicate crossing points per marker
were averaged per independent experiment (n¼ 4). Significance was
depicted between time points. Values were normalized to levels of b-
actin from the same pool for fold differences.
Statistics. Level of significance was set at p, 0.5 by ANOVA test on
the influence of genotype and sex, and subsequent pairwise mean
comparisons performed by Student t- or post hoc (Bonferroni) tests.
All statistics were calculated using the Prism 4 (GraphPad, USA) and
SigmaStat v. 3.1 (Systat Software, Germany) software.
Supporting Information
Figure S1. Genome-Wide Linkage and High-Resolution Haplotype
Analysis of the Aga2 Locus
(A) Genome-wide linkage analysis revealed Aga2 linkage on mouse
distal Chromosome 11.
(B) Haplotype analysis identified the most probable Aga2 candidate
region between D11Mit288 and D11Lis2. Log of odds ratio (LOD),
centimorgan (cM), megabase (Mb), and (black) heterozygous (C3HeB/
FeJ & C57BL/6 alleles), (white) homozygous (C57BL/6 allele).
Found at doi:10.1371/journal.pgen.0040007.sg001 (855 KB TIF).
Figure S2. In Vivo Bone Formation and Resorption in 16-Wk-Old
Male Mice
(A,B) Bone formation and mineral accretion were monitored by dual
calcein (red arrows) and tetracycline (white arrows) in vivo labeling
(dL). Tibial secondary cancellous (c, inset) and endocortical (not
shown) regions were characterized. Bar, 100 lm for main in (A) and
(B) combined. Bracketed bars within the corner boxes represent
mean 6 SEM of sample dL lengths (17.9 6 0.6 lm/7 d,þ/þ; and 11.7 6
1.0 lm/7 d, Aga2/þ).
(C,D) Undecalcified tibial sections in control and Aga2/þ, respectively,
depict increased resorptive bays with multinucleated OCs (black
arrows) at the osteogenic zone, and extended hypertrophic zone of
the growth plate (Gp; horizontal arrow) in Aga2. Bar, 100 lm
combined; stained with von Kossa and countered with Paragon. Bone
marrow (Bm), trabecula (Tb).
Found at doi:10.1371/journal.pgen.0040007.sg002 (9.2 MB TIF).
Figure S3. Quantitative Analysis of Physiological Bone Growth and
Remodeling in 16-Wk-Old Male Tibiae
(A) Percentage of secondary trabecular surface encompassed with
OBs.
(B) MAR calculated within both secondary cancellous (c) and
endocortical (EC) bones, while BFR was calculated for mid-cancellous
bones.
(C) Relative number of TRAP-positive OCs within secondary
trabeculae.
(D) Cell density within femora and tibiae.
Bars represent mean 6 SEM, where n ¼ 4 in (A–C), and n ¼ 6
experiments in (D). p-Values in (A–C) derived from the Student t-test,
while in (D), *p , 0.0001 one-way ANOVA and **p , 0.001 post hoc
test. Diaphysis (d), metaphysis (m), cortex (Cx), trabeculae (Tb).
Found at doi:10.1371/journal.pgen.0040007.sg003 (2.0 MB TIF).
Figure S4. Aga2/þOsteoblastic Ex Vivo Response and Function
(A) ALP activity measurement in primary OB lysates.
(B) OB total protein, reduced MTT, and secreted acid-soluble
collagen levels at 21 days in culture.
(C) Time-course analysis of the density and individual area of bone-
like nodules, and the amount of bounded alizarin red dye per total
nodule area at 16 days. Asterisks show significant differences at *p ,
0.05, **p , 0.001, and ***p , 0.0001 (Student t-test), while
stimulated-unstimulated p-values were derived from ANOVA with
post hoc test. Values represent mean 6 SEM, where n ¼ 4–5
independent experiments. 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl
tetrazolium bromide (MTT), unstimulated (unstim.).
Found at doi:10.1371/journal.pgen.0040007.sg004 (2.4 MB TIF).
Table S1. Dysmorphology
Found at doi:10.1371/journal.pgen.0040007.st001 (106 KB DOC).
Table S2. In Vivo pQCT Analysis in Paternal-Derived 16-Wk-Old
Male Femur
Found at doi:10.1371/journal.pgen.0040007.st002 (61 KB DOC).
Table S3. Clinical Chemical Analysis at 12–16 Wk of Age
Found at doi:10.1371/journal.pgen.0040007.st003 (54 KB DOC).
Table S4. Histomorphometry
Found at doi:10.1371/journal.pgen.0040007.st004 (35 KB DOC).
Accession Numbers
Col1a1, MGI:88467 (murine) and HGNC:2187 (human); Chad,
MGI:1096866; Hspa5 (BiP), MGI:95835; Serpinh1 (Hsp47), MGI:88283;
Ddit3 (Gadd153), MGI:109247. Data depicted from Mouse Genome
Informatics (MGI; www.informaticts.jax.org) and HUGO Gene no-
menclature Committee (HGNC; http://www.genenames.org).
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